The Effect of FcγRIIIA Gene Polymorphism on the Treatment of Diffuse Large B-cell Non-Hodgkin Lymphoma: A Multicenter Prospective Observational Study

OBJECTIVE: The curative treatment approach for diffuse large B-cell lymphoma (DLBCL) is controversial even in the rituximab (R) era. The aim of this study was to examine the FcγRIIIA gene polymorphism distribution of DLBCL patients who had been treated with R-CHOP (cyclophosphamide, doxorubicin, vin...

Descripción completa

Detalles Bibliográficos
Autores principales: Büyükkurt, Nurhilal, Özcan, Mehmet Ali, Ergene, Ülkü, Payzın, Bahriye, Tunalı, Sunay, Demirkan, Fatih, Özsan, Hayri, Pişkin, Özden, Ündar, Bülent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Galenos Publishing 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4451483/
https://www.ncbi.nlm.nih.gov/pubmed/26316483
http://dx.doi.org/10.4274/tjh.2013.0367

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4451483/
https://www.ncbi.nlm.nih.gov/pubmed/26316483
http://dx.doi.org/10.4274/tjh.2013.0367

Ejemplares similares